Bio-Rad Laboratories, Inc. (BIO:NYSE) closed at $369.95 on October 23, 2026, up 1.77% on the day. The stock trades 6.6% below its 52-week high of $396.23 and 56.3% above its 52-week low of $236.73. Over the past year, it gained 8.9%. Bio-Rad Laboratories, Inc. is part of the Capital Goods sector (Biotechnology: Laboratory Analytical Instruments).
In 252 trading sessions since October 23, 2025, BIO closed higher on 119 days (47%). Its best day was May 18, 2026 (+13.85%) and its worst was February 13, 2026 (-12.26%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and softwar...
Find more stocks like BIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.